University Hospital Cleveland

Cleveland, Ohio 44106

1 studies enrolling now · 9 studies all time

What they study most

Brain Hemorrhage, Brain Metastases, Cerebral Hemorrhage, Cerebral Parenchymal Hemorrhage, Coronary Artery Disease, Heart Failure, Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Valve Disease, Intracerebral Hemorrhage, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction

Studies at this site

• PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III — Recruiting now
• MIND: Artemis in the Removal of Intracerebral Hemorrhage — Completed
• Study to Establish the Diagnostic Performance of 18F Fluciclovine PET in Detecting Recurrent Brain Metastases — Completed
• Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) — Completed
• Randomized On-X Anticoagulation Trial — Completed
• S-ICD® System Post Approval Study — Completed
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial — Running, not enrolling
• Optimal Platelet Dose Strategy for Management of Thrombocytopenia — Completed
• Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) — Stopped early